Back to Search Start Over

Renal Genetics Clinic: 3-Year Experience in the Cleveland ClinicPlain-Language Summary

Authors :
Xin Yee Tan
Chloe Borden
Mary-Beth Roberts
Sarah Mazzola
Queenie K.-G. Tan
Richard Fatica
James Simon
Juan Calle
Jonathan Taliercio
Katherine Dell
Laura Ferreira Provenzano
Diana Deitzer
Hernan Rincon-Choles
Ali Mehdi
Michael Lioudis
Emilio D. Poggio
Georges Nakhoul
Saul Nurko
Tarek Ashour
Raed N. Bou Matar
Charles Kwon
Brian Stephany
George Thomas
Yu-Wei Cheng
Deanna Leingang
Adnan Alsadah
Rhyan Maditz
Heyka Robert
Tushar Vachhrajani
John Sedor
Crystal Gadegbeku
Xiangling Wang
Source :
Kidney Medicine, Vol 5, Iss 2, Pp 100585- (2023)
Publication Year :
2023
Publisher :
Elsevier, 2023.

Abstract

Rationale & Objective: There has been an increasing demand for the expertise provided by a renal genetics clinic. Such programs are limited in the United States and typically operate in a genomics research setting. Here we report a 3-year, real-world, single-center renal genetics clinic experience. Study Design: Retrospective cohort. Setting & Participants: Outpatient cases referred to the renal genetics clinic of the Cleveland Clinic between January 2019 and March 2022 were reviewed. Analytical Approach: Clinical and laboratory characteristics were analyzed. All genetic testing was performed in clinical labs. Results: 309 new patients referred from 15 specialties were evaluated, including 118 males and 191 females aged 35.1 ± 20.3 years. Glomerular diseases were the leading presentation followed by cystic kidney diseases, electrolyte disorders, congenital anomalies of kidneys and urinary tract, nephrolithiasis, and tubulointerstitial kidney diseases. Dysmorphic features were noted in 27 (8.7%) patients. Genetic testing was recommended in 292 (94.5%) patients including chromosomal microarray (8.9%), single-gene tests (19.5%), multigene panels (77.3%), and exome sequencing (17.5%). 80.5% of patients received insurance coverage for genetic testing. 45% (115/256) of patients had positive results, 25% (64/256) had variants of unknown significance, and 22.3% (57/256) had negative results. 43 distinct monogenic disorders were diagnosed. Family history of kidney disease was present in 52.8% of patients and associated with positive genetic findings (OR, 2.28; 95% CI, 1.40-3.74). 69% of patients with positive results received a new diagnosis and/or a change in the diagnosis. Among these, 39.7% (31/78) of patients received a significant change in disease management. Limitations: Retrospective and single-center study. Conclusions: The renal genetics clinic plays important roles in the diagnosis and management of patients with genetic kidney diseases. Multigene panels are the most frequently used testing modality with a high diagnostic yield. Family history of kidney disease is a strong indication for renal genetics clinic referral.

Details

Language :
English
ISSN :
25900595
Volume :
5
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Kidney Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.6b849a4034d44aa5b072e20c0f99cd74
Document Type :
article
Full Text :
https://doi.org/10.1016/j.xkme.2022.100585